Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2018.01367
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Challenging the Management of Drug-Resistant Tuberculosis

The Lancet
Medicine
2020English

New Approaches to Filling the Gap in Tuberculosis Drug Discovery

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2007English

The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

The Implications of Model-Informed Drug Discovery and Development for Tuberculosis

Drug Discovery Today
Drug DiscoveryPharmacology
2017English

Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin

Organic Letters
BiochemistryOrganic ChemistryTheoretical ChemistryPhysical
2014English

From Linear ‘Dogma‘ and Trastuzumab–emtansine to Future Transcriptional Circuitry-Based Drug Discovery for Breast Cancer

Future Oncology
MedicineCancer ResearchOncology
2014English

Drug Discovery

Journal of Antivirals & Antiretrovirals
2010English

Epigenetic Protein Families: A New Frontier for Drug Discovery

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2012English

Drug Repositioning for Enzyme Modulator Based on Human Metabolite-Likeness

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy